Senators Introduce ‘Safe Medical Devices Act’
A bipartisan group of U.S. senators is pushing a bill that supporters say will make medical devices safer, according to the Association for the Advancement of Medical Instrumentation (AAMI).
If approved, the Ensuring Safe Medical Devices for Patients Act would require the U.S. Food and Drug Administration (FDA) to release its long-awaited unique device identifier (UDI) rule this year. The FDA would also have to add devices to its Sentinel postmarketing surveillance initiative, which monitors prescription drug safety.
The legislation, introduced March 15, 2012, comes at a time when the medical device industry is pressing Congress to streamline the federal review process for new devices, saying it is slow and complicated, impeding innovation. Patient safety advocates, on the other hand, say the oversight process is not strict enough.
President Obama said during his State of the Union address in January that “smart regulations” could help prevent “faulty medical devices” from hitting the market. In a press release, one of the bill’s sponsors cited patient safety as motivation for the legislation.
“When seniors undergo hip replacement surgery or heart patients need a cardiac stent, they shouldn’t have to worry that the device that is supposed to improve their health could actually make them sicker,” said Sen. Jeff Merkley, D-OR, who introduced the bill with Sens. Chuck Grassley, R-IA, Michael Bennett, D-CO, and Herb Kohl, D-WI. “Strong postmarketing surveillance of medical devices will ensure those that are defective or cause harm can be quickly identified, patients and their physicians can be notified, and dangerous products can be removed from the market.”
The agency has worked on the UDI rule since it became a requirement under the Food and Drug Administration Amendments Act of 2007. FDA officials have said that the draft rule is going through the Office of Management and Budget’s approval process. Once finalized, manufacturers must put a UDI barcode on devices so they can be identified.
The Advanced Medical Technology Association (AdvaMed), a device trade association based in Washington, D.C., gave a measured response to the legislation.
“The appropriate development and use of UDI and the postmarket risk identification and analysis system known as Sentinel should further enhance FDA’s already robust postmarket authorities,” said Stephen J. Ubl, AdvaMed president and chief executive officer, in a statement. “We are reviewing the bill and look forward to working with Sen. Merkley and other members of Congress on these issues.”
To read the press release from Merkley, CLICK HERE.
Source: Association for the Advancement of Medical Instrumentation (AAMI)
- Consumer Reports taps ire over bad medical devices (earlsview.com)
- Consumer Reports Poll: Consumers Support More Medical Device Oversight (earlsview.com)
- Howard Sdwin: What isn’t being published is the truth regarding the medical device world (earlsview.com)
- Mesh Medical Device Newsdesk (earlsview.com)
- Reforming the 510(k) Process: Where We Are, How We Got Here, and What’s to Come | MDDI Medical Device and Diagnostic Industry News Products and Suppliers (earlsview.com)
- FDA seeks to include more women in medical device trials (earlsview.com)
- FDA probes JNJ, Bard and others on transvaginal mesh risks | MassDevice – Medical Device Industry News (earlsview.com)
- What Universal Device Identifiers Could Do For EHRs (informationweek.com)
- Howards View on the FDA and Medical Device Failures (earlsview.com)
- Cardiac medical device company Kips Bay Medical promotes CFO to COO (medcitynews.com)